Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 90 | 1 | 11 | 0 | €996.00 | €1,064.7 | 6.896% |
| Boston Scientific | 77 | 0 | 11 | 0 | €40.52 | €83.22 | 105.383% |
| UnitedHealth Group Inc. | 77 | 3 | 12 | 0 | €359.40 | €369.16 | 2.714% |
| Abbott Laboratories | 69 | 0 | 10 | 0 | €91.70 | €114.37 | 24.723% |
| Gilead Sciences Inc | 65 | 0 | 5 | 0 | €112.92 | €128.14 | 13.483% |
| Neurocrine Bioscience | 64 | 0 | 12 | 0 | €144.65 | €157.23 | 8.699% |
| Ionis Pharmaceuticals Inc. | 64 | 1 | 10 | 0 | €44.91 | €79.22 | 76.398% |
| Insmed Inc. | 63 | 1 | 4 | 0 | €87.50 | €173.11 | 97.845% |
| Insulet Corp. | 60 | 1 | 3 | 0 | €143.45 | €305.21 | 112.763% |
| Johnson & Johnson | 56 | 0 | 12 | 0 | €222.35 | €227.33 | 2.238% |
| Dexcom Inc. | 58 | 2 | 9 | 0 | €72.40 | €75.82 | 4.720% |
| HCA Holdings Inc. | 55 | 2 | 8 | 2 | €349.20 | €435.61 | 24.746% |
| Alnylam Pharmace. | 50 | 0 | 10 | 0 | €178.25 | €428.30 | 140.279% |
| Regeneron Pharmaceuticals Inc. | 46 | 0 | 7 | 0 | €661.60 | €728.50 | 10.112% |
| Vertex Pharmaceuticals Inc. | 47 | 1 | 3 | 1 | €413.65 | €467.05 | 12.909% |
| Tenet Healthcare | 44 | 0 | 12 | 0 | €222.00 | €217.45 | -2.049% |
| AbbVie Inc. | 43 | 0 | 10 | 0 | €217.70 | €227.75 | 4.614% |
| Biogen Inc. | 43 | 1 | 10 | 1 | €176.04 | €197.12 | 11.973% |
| Jazz Pharmaceuticals plc | 41 | 0 | 5 | 0 | €219.20 | €222.07 | 1.310% |
| Cytokinetics Inc. | 41 | 0 | 0 | 0 | €66.88 | €77.92 | 16.513% |
| Medtronic plc | 41 | 1 | 2 | 0 | €74.08 | €97.41 | 31.486% |
| Rhythm Pharmaceuticals | 36 | 1 | 2 | 0 | €91.50 | €116.89 | 27.747% |
| Amgen Inc. | 36 | 2 | 2 | 0 | €334.10 | €332.22 | -0.564% |
| Agilent Technologies Inc. | 33 | 0 | 0 | 0 | €120.00 | €137.44 | 14.533% |
| Cigna Corp. | 32 | 0 | 0 | 0 | €242.00 | €288.04 | 19.025% |